292 related articles for article (PubMed ID: 22759382)
21. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
[TBL] [Abstract][Full Text] [Related]
22. Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer.
Riaz SK; Khan JS; Shah STA; Wang F; Ye L; Jiang WG; Malik MFA
Cell Commun Signal; 2018 Jan; 16(1):3. PubMed ID: 29329585
[TBL] [Abstract][Full Text] [Related]
23. Identifying cancer biomarkers by network-constrained support vector machines.
Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
[TBL] [Abstract][Full Text] [Related]
24. AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Stavnes HT; Nymoen DA; Langerød A; Holth A; Børresen Dale AL; Davidson B
Virchows Arch; 2013 Feb; 462(2):163-73. PubMed ID: 23242172
[TBL] [Abstract][Full Text] [Related]
25. G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer.
Oshi M; Takahashi H; Tokumaru Y; Yan L; Rashid OM; Matsuyama R; Endo I; Takabe K
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331421
[TBL] [Abstract][Full Text] [Related]
26. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.
Iglesia MD; Vincent BG; Parker JS; Hoadley KA; Carey LA; Perou CM; Serody JS
Clin Cancer Res; 2014 Jul; 20(14):3818-29. PubMed ID: 24916698
[TBL] [Abstract][Full Text] [Related]
27. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Iwamoto T; Bianchini G; Booser D; Qi Y; Coutant C; Shiang CY; Santarpia L; Matsuoka J; Hortobagyi GN; Symmans WF; Holmes FA; O'Shaughnessy J; Hellerstedt B; Pippen J; Andre F; Simon R; Pusztai L
J Natl Cancer Inst; 2011 Feb; 103(3):264-72. PubMed ID: 21191116
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
[TBL] [Abstract][Full Text] [Related]
29. Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.
Wang DY; Done SJ; Mc Cready DR; Leong WL
Breast Cancer Res; 2014 Jul; 16(4):R71. PubMed ID: 24996446
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
32. Identification of diagnostic subnetwork markers for cancer in human protein-protein interaction network.
Su J; Yoon BJ; Dougherty ER
BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S8. PubMed ID: 20946619
[TBL] [Abstract][Full Text] [Related]
33. An algorithm for expanding the TNM staging system.
Chen D; Hueman MT; Henson DE; Schwartz AM
Future Oncol; 2016; 12(8):1015-24. PubMed ID: 26904925
[TBL] [Abstract][Full Text] [Related]
34. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
35. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Bouchal P; Dvořáková M; Roumeliotis T; Bortlíček Z; Ihnatová I; Procházková I; Ho JT; Maryáš J; Imrichová H; Budinská E; Vyzula R; Garbis SD; Vojtěšek B; Nenutil R
Mol Cell Proteomics; 2015 Jul; 14(7):1814-30. PubMed ID: 25903579
[TBL] [Abstract][Full Text] [Related]
36. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
37. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype.
Zhao H; Tang H; Xiao Q; He M; Zhao L; Fu Y; Wu H; Yu Z; Jiang Q; Yan Y; Jin F; Wei M
Mol Med Rep; 2016 Dec; 14(6):5261-5270. PubMed ID: 27779682
[TBL] [Abstract][Full Text] [Related]
38. Grade-specific diagnostic and prognostic biomarkers in breast cancer.
Jayanthi VSPKSA; Das AB; Saxena U
Genomics; 2020 Jan; 112(1):388-396. PubMed ID: 30851359
[TBL] [Abstract][Full Text] [Related]
39. SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer.
van Reesema LLS; Zheleva V; Winston JS; Jansen RJ; O'Connor CF; Isbell AJ; Bian M; Qin R; Bassett PT; Hinson VJ; Dorsch KA; Kirby BW; Van Sciver RE; Tang-Tan AM; Harden EA; Chang DZ; Allen CA; Perry RR; Hoefer RA; Tang AH
EBioMedicine; 2016 Sep; 11():183-198. PubMed ID: 27569656
[TBL] [Abstract][Full Text] [Related]
40. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]